Empowering Precision, Enhancing Lives, Focal Healthcare: Transforming Prostate Biopsy and Therapy through practical prostate cancer technology

Focal Healthcare emerges as a pioneering force in the realm of medical devices, dedicated to transforming the landscape of prostate biopsy and therapy. With an unwavering commitment to innovation and precision, the company is at the forefront of developing cutting-edge solutions that redefine medical practices.

At the heart of Focal Healthcare's groundbreaking initiatives lies the Fusion Bx™ system, a revolutionary MRI/TRUS Fusion targeted guidance system. This advanced technology empowers urologists with unparalleled accuracy by seamlessly co-registering MRI prostate images with real-time ultrasound. By doing so, it allows urologists to precisely target suspected cancerous regions during TRUS biopsy procedures, ushering in a new era of diagnostic precision and patient care.

Focal Healthcare's Fusion Bx™ system stands as a testament to the company's dedication to enhancing medical procedures. By bridging the gap between MRI imaging and live ultrasound, Focal Healthcare ensures that urologists can make well-informed decisions, leading to more accurate diagnoses and effective therapies. As a result, patients can expect a higher standard of care, marking a significant stride forward in the field of prostate health.

In the ever-evolving landscape of medical technology, Focal Healthcare stands as a beacon of innovation, driving advancements that have a tangible impact on patients' lives. With their state-of-the-art Fusion Bx™ system, Focal Healthcare is revolutionizing the approach to prostate biopsy and therapy, setting new standards in precision and reliability.

Fusion MR: Revolutionizing Prostate MRI Contouring

Fusion MR stands at the forefront of innovative medical software, specializing in interpreting MRIs of the prostate with unparalleled accuracy and efficiency. As a pivotal first step in targeted biopsy procedures, Fusion MR plays a crucial role in identifying suspicious regions of interest through its sophisticated color-coded contours. These meticulously marked-up MRIs serve as the foundation for the subsequent stages of diagnosis and treatment.

One of Fusion MR's standout features is its seamless integration into medical workflows. The software is fully compatible with PACS (Picture Archiving and Communication System), ensuring effortless collaboration and data sharing among medical professionals. What sets Fusion MR apart is its accessibility, as it comes with no upfront costs, making it a practical and cost-effective solution for healthcare institutions.

Navigating the Fusion MR interface is a streamlined experience, designed to enhance communication between radiology and urology teams. The software's intelligently simple interface enables swift and accurate contouring of regions of interest. Through high-speed contouring capabilities, Fusion MR supports fusion biopsy procedures, a vital component in diagnosing prostate conditions. The semi-automated segmentation process ensures precision while expediting the workflow, allowing medical professionals to focus on critical decision-making aspects of patient care.

Moreover, Fusion MR offers a dedicated study page, providing a centralized hub for comprehensive analysis. This study page serves as a pivotal resource, allowing medical experts to annotate lesions and perform in-depth examinations. By combining advanced technology with user-friendly features, Fusion MR becomes an indispensable tool in the realm of prostate MRI contouring, revolutionizing the way healthcare providers approach diagnostic procedures.

The targeted nature of Regions of Interest (ROIs) ensures that biopsies can be conducted with fewer cores, effectively avoiding the pitfalls of oversampling and undersampling. Furthermore, the Fusion software maintains a detailed record of core locations. This meticulous documentation guarantees the repeatability of biopsies, especially when cancer is precisely located. This level of reliability opens the door to active surveillance as a viable option for low-risk tumors, offering patients a feasible alternative.

In stark contrast, traditional biopsy methods blindly sample the prostate without any knowledge of the location of potential cancerous cells. This lack of precision often leads to ambiguity and delays in treatment decisions. MRI-targeted fusion biopsies, however, usher in a new era of care standards. By harnessing the power of MRI imaging, these biopsies provide a strategic action plan, offering patients the best opportunity for prompt and effective treatment.

Experience the future of prostate biopsies with MRI-targeted fusion biopsies—an approach that not only enhances precision but also ensures that patients receive optimal care, leading to swifter and more effective treatments.

Discover the Precision of Fusion Bx: Redefining Prostate Biopsy Accuracy

Fusion Bx, endorsed by medical professionals worldwide, has seamlessly integrated into clinics, transforming fusion biopsies into a routine part of their practice. As attested by Dr. Winston Barzell from 21st Century Oncology, USA, Fusion Bx has become an indispensable tool, ensuring accuracy and reliability during biopsy procedures.

This cutting-edge technology addresses three pivotal sources of inaccuracy encountered during biopsy procedures, making it a game-changer in the field of medical diagnostics:

Prostate Deformation: Inconsistent pressure on the prostate often leads to deformation, compromising targeting accuracy. Traditional freehand systems struggle to maintain consistent pressure, resulting in potential errors. Fusion Bx introduces a semi-robotic arm, a groundbreaking solution that prevents targeting errors by ensuring uniform pressure on the prostate. This innovation guarantees precision and reliability in every procedure.

Patient Motion: Patient discomfort can cause involuntary movements, impacting the accuracy of the biopsy. Fusion Bx incorporates a semi-robotic arm designed for maximum patient comfort. By allowing the probe to pivot at the patient's sphincter, it minimizes discomfort and motion, ensuring stable and precise biopsies. Additionally, the system features automatic motion compensation, effectively addressing minor patient movements to maintain accuracy throughout the procedure.

With Fusion Bx, medical professionals can rely on a comprehensive solution that guarantees accuracy, minimizes errors, and enhances the overall biopsy experience. By revolutionizing the way prostate biopsies are conducted, Fusion Bx sets a new standard in precision and reliability, ultimately benefiting both healthcare providers and patients alike.

Chicuong La, President and CEO

“Focal Healthcare was founded to fill the need for highly accurate, practical prostate cancer technology that is accessible to all urologists and their patients.”